Ad is loading...
PAADX
Price
$17.56
Change
-$0.16 (-0.90%)
Updated
Nov 15 closing price
RAMHX
Price
$35.93
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

PAADX vs RAMHX

Header iconPAADX vs RAMHX Comparison
Open Charts PAADX vs RAMHXBanner chart's image
Putnam Dynamic Asset Allocation Bal R5
Price$17.56
Change-$0.16 (-0.90%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R2E
Price$35.93
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
PAADX vs RAMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PAADX vs. RAMHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAADX is a StrongSell and RAMHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RAMHX has more cash in the bank: 236B vs. PAADX (2.11B). RAMHX (1.84) and PAADX (1.82) have matching dividends . PAADX was incepted earlier than RAMHX: PAADX (12 years) vs RAMHX (10 years). PAADX is a more actively managed with annual turnover of: 302.00 vs. RAMHX (171.00). PAADX has a lower initial minimum investment than RAMHX: PAADX (0) vs RAMHX (250). PAADX annual gain was more profitable for investors over the last year : 21.61 vs. RAMHX (20.31). RAMHX return over 5 years is better than : 32.43 vs. PAADX (27.91).
PAADXRAMHXPAADX / RAMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years10 years-
Gain YTD16.14813.582119%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.11B236B1%
Annual Yield % from dividends1.821.8499%
Returns for 1 year21.6120.31106%
Returns for 3 years-1.599.39-17%
Returns for 5 years27.9132.4386%
Returns for 10 years35.4946.7476%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVL344.74-1.93
-0.56%
CorVel Corp
FLUT265.45-1.55
-0.58%
Flutter Entertainment plc
INVA18.90-0.34
-1.77%
Innoviva
CMMB1.67-0.06
-3.74%
Chemomab Therapeutics Ltd
MVST0.72-0.06
-7.68%
Microvast Holdings